Delivery Order SPE2DB22D3501-SPE2DB25FWA97
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $4,436.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers, with a ceiling value of $1,112.74. This is a firm fixed-price, non-set-aside delivery order that is part of AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work is to be completed by August 15, 2025, with performance at the company's headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,458.34 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers. The contract is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's broader pharmaceutical supply agreement with DLA. This award was issued on July 10, 2025, with an ultimate completion date of July 11, 2025, and will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, with a ceiling value of $3,278.52. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement for...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWA97Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,853.12 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This non-competed delivery order, issued on June 16, 2025, with a completion date of June 17, 2025, is structured as a firm fixed-price contract for pharmaceutical supply to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving military and veteran healthcare systems. This delivery order represents a small-value transaction within AmerisourceBergen's broader relationship with the Defense Logistics Agency. The company holds a significant Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026) with DLA Troop Support Medical that serves as the parent contract vehicle for this delivery order. Through this comprehensive contract, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, vaccines, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/16/25 |